Axsome Therapeutics (19X) Q2 2023 Earnings Report
5 Followers
DE:19X Q2 2023 EPS Results
- Actual EPS
- -EUR 1.37
- Consensus EPS
- -EUR 1.08
- Beat/Miss
- Missed by -EUR 0.29
- One Year Ago EPS
- -EUR 0.94
DE:19X Q2 2023 Revenue Results
- Actual Revenue
- EUR 41.49M
- Expected Revenue
- EUR 36.32M
- Beat/Miss
- Beat by +EUR 5.17M
- YoY Revenue Growth
- +429.49%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/07/2023
- Time
- Before Open
- Conference Call
- Monday, August 7, 2023
DE:19X Upcoming Earnings
Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:19X Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:19X Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.07- | -0.5 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.56-0.22 | -0.84 | 73.40% (+0.61) | |
| Aug 10, 2026 | 2026 (Q2) | -0.79-0.88 | -0.86 | -2.06% (-0.02) | |
| May 04, 2026 | 2026 (Q1) | -0.75-1.12 | -1.08 | -3.28% (-0.04) | |
| Feb 23, 2026 | 2025 (Q4) | -0.62-0.50 | -1.37 | 63.64% (+0.87) | |
| Nov 03, 2025 | 2025 (Q3) | -0.77-0.84 | -1.19 | 29.85% (+0.36) | |
| Aug 04, 2025 | 2025 (Q2) | -0.94-0.86 | -1.48 | 41.92% (+0.62) | |
| May 05, 2025 | 2025 (Q1) | -1.20-1.08 | -1.28 | 15.28% (+0.20) | |
| Feb 18, 2025 | 2024 (Q4) | -0.89-1.37 | -1.85 | 25.96% (+0.48) | |
| Nov 12, 2024 | 2024 (Q3) | -1.23-1.19 | -1.17 | -1.52% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
